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INTRODUCTION 
 
 Benign breast disease is a common disorder. It is atleast 10 times more 
common than breast cancer in hospital clinics (1). The histological changes of benign 
breast disease are in reality part of the spectrum of changes that occur in the life time 
of breast tissue. These histological charges do not proceed as a smooth continuum; the 
individual elements often occur simultaneously and can give rise to anatomical 
(palpable) abnormalities such as nodularity (or) cystic change, which may initiate 
referral to hospital, but are not disease in the true sense of word. 
 
However an increasing interest in histology of the normal human breast with 
studies of autopsy and biopsy material, is providing a background which allowed a 
better understanding of what is normal and what is abnormal, thus helping to correct 
the tendency to overrate the malignant potential of benign Breast disease. 
  
 The term benign breast disease encompasses a wide range of clinical and 
pathological entities. Up to 30% of women may suffer from a benign breast disorder 
requiring treatment at sometime in their life. In general population on examination of 
breast grossly evident cystic changes were found in 20% but histological evidence of 
cystic changes were found in 59% of women(2). In patients attending breast clinic for 
various breast problems, 40% of patients were found to be having fibrocystic changes 
and about 7% having fibroadenoma. 
 Hence benign breast disease requires imaging studies for evaluations. 
Mammography and ultrasound are the most useful tools for this purpose. 
Mammography is used as a primary tool in benign breast disease and also as a 
screening tool to detect early breast cancer. 
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 Ultrasound is used to differentiate cystic lesions from solid lesions and 
particularly useful in dense breast seen in young women. Both of these tools are also 
useful in localizing to lesion and in guiding biopsy. 
 
Hence both ultrasound and Mammography are the pillars on which the edifice of 
this study is built. 
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AIM OF THE STUDY 
 
• To compare the utility of mammography and sonography in the diagnosis of 
benign breast diseases.  
• To study the utility of 3D Ultrasound in the evaluation of Benign Breast lesions. 
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REVIEW OF LITERATURE 
 
DEVELOPMENT OF THE BREAST 
The first indication of mammary glands is found in the form of a band like 
thickening of the epidermis as the mammary line (or) mammary ridge (3). In a seven 
week embryo this line extends on each side of the body from the base of the forelimb to 
the region of the hind limb. Although the major part of the mammary line disappears 
shortly after it forms, a small portion in the thoracic region persists and penetrates the 
underlying mesenchyme. Here it forms 16 to 24 sprouts, which in turn give rise to small 
solid buds.  By the end of prenatal life the epithelial sprouts are canalized and form to 
lactiferous ducts and the buds form small ducts and alveoli of the gland. 
 
Initially the lactiferous ducts open in to small epithelial pit. Shortly after birth this 
pit is transformed in to the nipple by proliferation of the underlying mesenchyme. 
 
Figure shows the Anatomy of the duct system of the breast. 
1. Collecting duct 2. Lactiferous sinus. 3. Segmental duct. 4. Subsegmental 
duct. 5. Terminal duct lobular units (TDLU) arising from subsegmental duct. 
(Recent advances 11 – Taylor)(4) 
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The TDLU  
1. Subsegmental duct.   2. Extralobular terminal duct.  
3. Intra lobular terminal duct.  4. Ductule 
(Recent advances 11 – Taylor)(4) 
 
 
ANATOMY OF THE BREAST 
The breasts consist of mammary and associated skin and connective tissues. 
The mammary glands are modified sweat glands which consist of a series of ducts and 
associated secretory lobules. These converge to form 15 to 20 lactiferous ducts, 
opening independently on to the nipple. The nipple is surrounded by a circular 
pigmented area of skin termed the areola. 
 
A well developed connective tissue stroma surrounds the ducts and lobules of 
the mammary gland. In certain regions, these condense to form well defined ligaments 
(the suspensory ligaments of Astley cooper) which are continuous with the dermis of 
the skin and support the breast. 
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In non-lactating women the predominant component of the breast is fat, while 
glandular tissue is more abundant in lactating women. The breast lies on deep fascia 
related to the pectoralis major muscle and other surrounding muscles. 
 
A layer of the loose connective tissue (the retro mammary space) separates the 
breast from the deep fascia and provides some degree of movement over underlying 
structures. The base (or) attached surface of each breast extends vertically from Ribs II 
to VI and transversely from the sternum to as far laterally as the mid axillary line. A 
small extension called the axillary tail of Spence pierces the deep fascia and lies in the 
axilla.  Breast in the male is rudimentary and consists only of small ducts often 
composed of cords of cells that normally do not extend beyond the areola. 
 
BLOOD SUPPLY OF THE BREAST (5):  
This is derived from 
1. The lateral thoracic artery, from the 2nd part of the axillary artery. 
2. The perforating cutaneous branches of the internal mammary artery to the 
2nd, 3rd and 4th spaces. 
3. The lateral branches of the 2nd, 3rd and 4th intercostal arteries. 
 
VENOUS DRAINAGE 
The superficial veins radiate from the breast and are characterized by their 
proximity to the skin. They are accompanied by lymphatics and drain to axillary internal 
mammary and intercostals vessels. 
 
LYMPHATIC DRAINAGE (6): 
The surgeons customarily describe 6 groups of nodes in relation to the axillary vein: 
1) Axillary vein group (lateral) that consists of 4-6 lymph nodes, which lie medial or 
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posterior to the vein and receive most of the lymph drainage from the upper extremity. 
2) External mammary group (anterior or pectoral group) that consists of 5-6 lymph 
nodes which lie along the lower border of the pectoralis minor muscle contiguous with 
the lateral thoracic vessels and receive most of the lymph drainage from the lateral 
aspect of the breast; 3) the scapular group (posterior or subscapular) that consists of 5 
to 7 lymph nodes, which lie along the posterior wall of the axilla at the lateral border of 
the scapula contiguous with the subscapular vessels and receive lymph drainage 
principally from the lower posterior neck, the posterior trunk, and the posterior shoulder; 
4) the central group that consists of 3 or 4 sets of lymph nodes, which are embedded in 
the fat of the axilla lying immediately posterior to the pectoralis minor muscle and 
receive lymph drainage both from the axillary vein, extern, mammary, and scapular 
groups of lymph nodes and directly fro the breast; 5) the subclavicular group (apical) 
that consists of 6 12 sets of lymph nodes, which lie posterior and superior to the upper 
border of the pectoralis minor muscle and receive lymph drainage from all of the other 
groups of axillary lymph nodes; and 6) the interpectoral group (Rotter's) that consists of 
1 to 4 lymph node which are interposed between the pectoralis major and pectoralis 
minor muscles and receive lymph drainage directly from the breast. The lymph fluid that 
passes through the interpectoral group of lymph nodes passes directly into the central 
and subclavicular groups. 
 
As indicated in Figure, the lymph node groups are assigned levels according to 
their relationship to the pectoralis minor muscle. Lymph nodes located lateral to or 
below the lower border o the pectoralis minor muscle are referred to as level I lymph 
nodes; which include the axillary vein, external mammary, and scapular groups. Lymph 
nodes located superficial or deep to the pectoralis minor muscle are referred to as level 
II lymph nodes, which include the central and interpectoral groups. Lymph nodes 
located medial to or above the upper border of the pectoralis minor muscle are referred 
to as level III lymph nodes, which consist of the subclavicular group.  
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The plexus of lymph vessels in the breast arises in the interlobular connective 
tissue and in the walls of the lactiferous duct and communicates with the subareolar 
plexus of lymph vessels. Efferent lymph vessels from the breast pass around the lateral 
edge of the pectoralis major muscle and pierce the clavipectoral fascia ending in the 
external mammary (anterior, pectoral) group of lymph nodes. Some lymph vessels may 
travel directly to the subscapular (posterior, scapular) group of lymph nodes. From the 
upper part the breast, a few lymph vessels pass directly to the subclavicular (apical) 
group of lymph nodes. The axillary lymph nodes usually receive more than 75% of the 
lymph drainage from the breast. The rest is derived primarily from the medial aspect of 
the breast, flows through the lymph vessels that accompany the perforating branch of 
the internal mammary artery, and enters the parasternal (internal mammary) group of 
lymph nodes. 
 
BREAST IMAGING 
 Mammography has proved to be the single most important technique for 
symptomatic and asymptomatic women. Symptomatic women with a known palpable 
mass or a suspicious area of the breast require diagnostic problem solving 
mammography. The first dedicated mammography machine was developed in 1966. 
Until this time, mammographic images had been produced by simply using a 
Conventional Radiography machine. In 1967, a research team designed a basic unit, 
incorporating a more specific X-ray spectrum and tube to better focus on the breast 
tissue and chest cavity. Through a dedicated design and the implementation of 
molybdenum, a strong metal component, this machine (a tube and a lens on a three-
legged stand) produced better quality images than make-shift mammograms from a 
conventional radiography equipment of that era. The first commercial model of the 
“Senographe” (French for “picture of the breast”) as it was called, became available in 
1967. In the early 80’s, the first motorized compression device was born. Today women 
can expect state-of-the-art results from machines that use Rhodium, a metal element in 
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the X-ray tube that enables better penetration of the breast tissue with less radiation 
exposure to the patient. Rhodium technology is especially helpful for women with dense 
breasts (up to one third of the female population) who were not benefiting from 
mammography before Rhodium was applied to breast imaging equipment. 
Rhodium 
 
Name: rhodium   Symbol: Rh  
Atomic number: 45  Atomic weight: 102.90550 (2)   
Group number: 9  Group name: Precious metal or Platinum group metal  
Period number: 5   Block: d-block  
 
The use of rhodium filtration over others in thick breasts is because of the 
lower administered dose and of shorter exposure time with direct magnification . 
(Radiol Med (Torino). 1994 Sep; 88(3):295-300.) (7). 
 
Remarkably ultrasound of the breast has been performed both in vitro and 
clinically for 53 years. The first clinical application of breast ultrasound was reported in 
1954 by Wild and Reid. The focus was however clearly on the goal of distinguishing 
benign and malignant lesions and the results were remarkably accurate in this regard. 
A major improvement occurred in 1969 with the introduction of grey scale imaging. In 
the late 1960’s Kelly-fry et al (USA) attempted characterization of known masses with 
an effort toward early detection of sub clinical lesions. Theirs was the first attempt to 
identify the different structural elements of the mammary gland.   
 
The early 1980's brought digital technology to the field of ultrasound in general, 
and breast ultrasound in particular. Later, in the early 1990’s digital beam formers and 
broad band width capabilities led to developments such as tissue harmonics and real 
time spatial compounding. More recently, the use of color Doppler and power Doppler 
analysis of the blood supply to breast tumors has clearly increased the specificity of 
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clinical breast ultrasound but still falls short of the goal of 100% specificity in 
differentiating benign and malignant entities. 
THREE DIMENSIONAL ULTRASOUND OF BREAST MASS  
 In patients with benign cystic masses the pericystic breast parenchyma is 
compressed and pushed and hence shows a compressive pattern, however the 
margins are smooth  (8). 
 
 In patients with duct ectasia 3D ultrasound helps us by giving a cube of volume. 
When the cube is sliced through the region of interest and rotated the ducts will be 
seen coursing from the nipple to the deeper tissues. 
 
 In the case of fibroadenomas 3 D ultrasound is useful in seeing the margins of 
the lesion. Measurements are best taken in the coronal view as this gives the widest 
measurement.  
 
Malignant lesions have the characteristic ‘Retraction pattern’ surrounding the 
lesion due to traction on the surrounding tissues by the intense desmoplastic reaction 
and infiltration. 3D vascular reconstructions can sometimes aid in the diagnosis of 
malignancy by showing a distorted vascular branching pattern. 
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LOCALISATION OF LESION 
Lesions   on mammography are localized as medial or lateral with respect to its 
location on the cephalo-caudal view and superior or inferior with respect to the lateral or 
medio-lateral oblique view. It is then assigned to that particular quadrant of the breast 
as in supero-lateral, infero-lateral, supero-medial or infero-medial. 
 
   Lesions on sonography are localized with respect to their clock position, plane 
of the lesion and distance from the nipple. They are marked as 1, 2 or 3 depending on 
their proximity to the nipple with lesions within the circumference of 1 being closer to 
the nipple. Lesions are marked as A, B or C depending on the plane of the lesion,       
A) being in the skin or subcutaneous plane, B) in the mammary layer and C) in the retro 
mammary layer. For example, a lesion at 12 2 C is at 12 o clock position mid-way from 
the nipple and in the retro-mammary layer.  
 
 
 
SONOGRAPHIC LOCATION OF A MAMMOGRAPHIC LESION 
  Lesions which are lateral on the CC view will lie lower in the breast than 
suggested by its location on the MLO view. Lesions which are medial will be located 
more superiorly than suggested by the MLO projection. Mammograms are performed in 
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only 2 or 3 projections with the breast pulled away from the chest wall while 
sonography is generally performed with the patient supine and the gland flattened 
against the chest wall. Therefore the distance of the lesion from the chest wall cannot 
be estimated correctly. Lesions deep within the breast tissue on the mammogram may 
be superficial on sonography. 
 
BREAST IMAGING- REPORTING AND DATA SYSTEMS (BI-RADS) LEXICON FOR 
BREAST LESIONS 
MASS 
 
A "Mass" is a space occupying lesion seen in two different 
projections. If a potential mass is seen in only a single 
projection it should be called a "Density" until its three-
dimensionality is confirmed. 
Circumscribed (well-defined or sharply-defined) margins: 
The margins are sharply demarcated with an abrupt transition 
between the lesion and the surrounding tissue. Without 
additional modifiers there is nothing to suggest infiltration.  
Indistinct (ill defined) margins: The poor definition of the 
margins raises concern that there may be infiltration by the 
lesion and this is not likely due to superimposed normal breast 
tissue.  
Spiculated Margins: The lesion is characterized by lines 
radiating from the margins of a mass. 
ARCHITECTURAL 
DISTORTION 
The normal architecture is distorted with no definite mass 
visible. This includes spiculations radiating from a point, and 
focal retraction or distortion of the edge of the parenchyma. 
Architectural distortion can also be an associated finding. 
ASYMMETRIC DENSITY  This is a density that cannot be accurately described using the 
other shapes. It is visible as asymmetry of tissue density with 
similar shape on two views, but completely lacking borders 
and the conspicuity of a true mass. It could represent an 
island of normal breast, but its lack of specific benign 
characteristics may warrant further evaluation. Additional 
imaging may reveal a true mass or significant architectural 
distortion.  
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CALCIFICATION Amorphous or Indistinct Calcifications: These are often 
round or "flake" shaped calcifications that are sufficiently small 
or hazy in appearance that a more specific morphologic 
classification cannot be determined.  
Pleomorphic or Heterogeneous Calcifications: These are 
usually more conspicuous than the amorphic forms and are 
neither typically benign nor typically malignant irregular 
calcifications with varying sizes and shapes that are usually 
less than 0.5 mm in diameter.  
Fine, Linear or Fine, Linear, Branching (Casting) 
Calcifications: These are thin, irregular calcifications that 
appear linear, but are discontinuous and under 0.5 mm in 
width. Their appearance suggests filling of the lumen of a duct 
involved irregularly by breast cancer.  
Benign Calcifications: Benign calcifications are usually 
larger than calcifications associated with malignancy. They 
are usually coarser, often round with smooth margins and are 
much more easily seen. 
 
ASSESSMENT CATEGORIES 
Category 1 / Negative  There is nothing to comment on. The breasts are 
symmetrical and no masses, architectural disturbances or 
suspicious calcifications present 
Category 2 / Benign 
Finding  
This is also a negative mammogram, but the interpreter may 
wish to describe a finding. Involuting, calcified 
fibroadenomas, multiple secretory calcifications, fat 
containing lesions such as oil cysts, lipomas, galactoceles, 
and mixed density hamartomas all have characteristic 
appearances, and may be labeled with confidence. The 
interpreter might wish to describe intramammary lymph 
nodes, implants, etc. while still concluding that there is no 
mammographic evidence of malignancy. 
Category 3 / Probably 
Benign Finding - Short 
Interval Follow-Up 
A finding placed in this category should have a very high 
probability of being benign. It is not expected to change over 
the follow-up interval, but the radiologist would prefer to 
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Suggested  establish its stability. Follow – up is done at 6 month 
intervals U/L and 1 year interval B/L for 2-3 years. 
Category 4 / Suspicious 
Abnormality - Biopsy 
Should Be Considered  
These are lesions that do not have the characteristic 
morphologies of breast cancer but have a definite probability 
of being malignant. The radiologist has sufficient concern to 
urge a biopsy. If possible, the relevant probabilities should 
be cited so that the patient and her physician can make the 
decision on the ultimate course of action. 
Category 5 / Highly 
Suggestive of 
Malignancy  
These lesions have a high probability of being cancer. 
Appropriate Action Should Be Taken 
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MAMMOGRAPHIC APPEARANCE OF NORMAL BREAST 
Young women’s breasts contain large proportion of glandular tissue which 
appears as soft tissue density on mammogram .In older women, when involution of 
glandular tissue has occurred most of the breast has fatty density. The junction 
between the subcutaneous and retro-mammary fat layers with the glandular tissue 
should consist of a series of curved margins. Other normal structures visible on the 
mammogram include nipple, skin, blood vessels, ducts, Cooper’s ligaments and axillary 
lymph nodes (refer fig-2). 
 
 
CRANIO-CAUDAL VIEW OF THE BREAST   
 
1. Single arrow denotes vessel;  
2. Double arrow denotes ligament of cooper  
3. Arrow heads denote skin 
  16
MEDIOLATERAL OBLIQUE VIEW OF THE BREAST 
 
a- nipple;    b- areola;   c- pectoralis muscle;  
d- vessel;    e- duct;   f- coopers ligament;  
g- fat;     h- glandular tissue;  i- skin fold;   
j- retro-mammary tissue. 
 
BREAST PARENCHYMAL PATTERNS: 
Breast density can be graded according to the following BI-RADS density categories: 
CATEGORY 1 :   Breast composed entirely of fat. 
CATEGORY 2 :   Breast composed of scattered fibroglandular densities that could 
obscure a lesion. 
CATEGORY 3 :  Breast tissue is heterogeneously dense which may reduce the 
sensitivity of mammography. 
CATEGORY 4 :  Extremely dense breast which lowers the sensitivity of 
mammography. 
 
a 
j 
d 
i 
e 
f 
h 
 b 
g 
c 
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Wolfe has described 4 parenchymal patterns of the breast based on the relative 
amounts of fat, epithelial and connective tissue densities as seen mammographically. 
N1  :    Normal. The breast parenchyma is of low density and has a large proportion of 
fat. No ducts are visible. 
P1:      Parenchyma is composed chiefly of fat with a prominent duct pattern in the 
anterior portion of the breast but involving less than quarter of breast volume. 
P2:       Prominent duct pattern which involves more than quarter of breast volume and 
with which there is often an associated nodular component. 
DY:     Increased density of breast parenchyma with or without areas of nodularity. The 
density often obscures the underlying duct pattern. 
 
                P2 and DY patterns have an increased risk of breast cancer as reported by 
Wolfe. But more recent studies have failed to confirm this association. Mammographic 
sensitivity decreases with increasing density of breast parenchyma.   
 
Developing breast has dense parenchymal pattern. With maturity, parenchyma 
assumes a transparent appearance. Breasts of nulliparous women involute more slowly 
than multiparous women. Hormone Replacement Therapy (HRT) may also be 
associated with symmetric or asymmetric increase in breast density (8) and it inhibits 
involutional processes causing persistence of dense P2 and DY patterns. 
 
ULTRASONOGRAPHIC ANATOMY   
            On ultrasound, breast is a multilayered structure. The skin and fibro glandular 
plate are relatively echogenic while the subcutaneous and retromammary fat layers are 
echopoor. Normal skin thickness measures around 0.5-2 mm except at the 
inframammary crease, cleavage and periareolar region where it is thicker. The 
subcutaneous fat layer is separated from glandular tissue by a well defined scalloped 
margin. The chest wall muscles are also echopoor in young patients but become more 
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echogenic with fatty infiltration of age. Ultrasound appearance of breast tissue depends 
on how much involution of glandular tissue has taken place. Young glandular breast 
contains a well defined layer of glandular tissue within which  round or oval  well 
defined echo poor fat lobules may be present. As involution takes place, the breast 
tissue shows fat lobules separated by fine curvilinear septa of increased echogenicity. 
Normal ducts are often visible particularly in the subareolar region as anechoic tubular 
structures.  
SONOGRAPHIC ANATOMY OF THE BREAST 
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BENIGN DISEASES OF THE BREAST 
 
CLASSIFICATION OF BENING BREAST DISORDERS (Schwartz’s Principles of   
Surgery, 8th Edition) (6) 
 
Non – Proliferative disorders of the breast 
- Cysts and apocrine metaplasia 
- Duct ectasia 
- Calcification 
- Fibro adenoma and related lesions  
 
Proliferative disorders without atypia 
- Sclerosing adenosis 
- Radial and complex sclerosing lesion 
- Ductal epithelial hyperplasia 
- Intraductal papillomas 
 
Atypical proliferative lesions 
- Atypical lobular hyperplasia 
- Atypical ductal hyperplasia 
 
Relative Risk of invasive breast cancer (Recent Advances 21 I. Taylor) (1) 
No Increased risk 
 Adenosis – sclerosing or florid 
 Hyperplasia (mild 2-4 epithelia cells in depth) 
 Apocrine metaplasia 
 Cysts – macro and / or micro 
 Duct ectasia and periductal mastitis 
 Mastitis (inflammation) 
 Fibroadenoma 
 Squamous metaplasia 
 Fibrosis 
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Slightly increased risk (1.5-2 times) 
 Hyperplasia, moderate or florid, solid or papillary 
 Papilloma with fibrovascular core 
 
Moderately increased risk (5 times) 
 A typical hyperplasia 
  Ductal Lobular 
  Lobular 
 
Insufficient data to assign a risk 
 Solitary papilloma of lactiferous duct 
 Radial scar lesion 
 
NOMENCLATURE 
 The basic principles underlying the aberration of normal development and 
involvement (ANDI) classification of benign breast conditions are 1) Benign breast 
disorders and diseases are related to the normal processes of reproductive life and to 
involution 2) There is a spectrum of breast condition that ranges from normal to 
disorder to disease; and 3) the ANDI classification encompasses all aspects of the 
breast condition, including pathogenesis and the degree of abnormality (6). The 
horizontal component of the following table defines ANDI along a spectrum from 
normal, to mild abnormality (disorder), to severe abnormality (disease). The vertical 
component defines the period during which the condition develops (6). 
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 Normal Disorder Diseases 
 
Early reproductive 
years age (15-25) 
 
Lobular development 
Stromal Development 
 
Nipple eversion 
 
Fibroadenoma 
Adolescent   hypertrophy 
 
Nipple inversion 
 
Giant Fibroadenoma 
Gigantomastia 
 
Subareolar abscess 
Mammary duct fistula 
 
Later reproductive 
years (age 25-40) 
 
Cyclical changes of 
menstruation 
 
Epithelial hyperplasia 
of pregnancy 
 
Cyclical mastalgia 
Nodularity  
 
Bloody nipple discharge 
 
Incapacitating 
mastalgia 
 
Involution 
(age 35-55) 
 
Lobular involution  
 
Duct involution 
Dilatation 
Scelerosis 
 
Epithelial turnover 
 
Macrocysts  
Sclerosing lesions 
 
Duct ectasia 
Nipple retraction 
 
Epithelial hyperplasia 
 
 
 
 
Periductal mastitis 
 
 
Epithelial hyperplasia 
with atypia 
 
GENERAL FEATURES  
Mammographically these lesions are well defined, oval or round, and may show 
a complete radiolucent halo around the periphery due to Mach effect or compressed fat 
tissue around the mass. When the lesion is mostly of fat density it is usually benign. 
They may show few gentle lobulations (< 3).Some lesions may regress in size over a 
period of time especially in post menopausal women. Skin thickening and architectural 
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distortion may or may not be present. Some lesions show benign forms of calcifications 
( coarse, discrete, smooth monomorphic with central lucency, tea cup, punctuate or 
scattered). 
 
On ultrasound they are oval or ellipsoid wider than deep (depth: width < 0.7)   
and aligned parallel to the skin. Smooth thin echogenic capsule with 2-3 gentle 
lobulations may be seen. They have variable echogenicity and are usually 
homogeneous with lateral edge shadowing and posterior enhancement. On color 
Doppler, vessels are seen to go around the mass. 
 
MASTALGIA 
Mastalgia – pain in breast – is the commonest breast symptom seen in both 
general practice and specialist referral clinics. Mastalgia as any other symptom, 
deserves full assessment and careful evaluation; it doest no imply any particular 
pathological process nor is it a diagnosis. 
 
HISTORICAL ASPECT 
Painful breasts are often regarded as part of a psychosomatic disorder (12). Sir 
Astley Cooper (1829) was aware of the syndrome of painful breasts but considered 
such complaints were of psychological origin and undeserving of further consideration: 
`The disease is met within persons of an irritable and nervous temperament, in whom 
there is excessive excitability of the system, accompanied by diminished power'. 
Fitzwilliam (1924) in his book on breast disease hardly mentions breast pain but 
devotes a whole chapter to hysterical breasts. Sir Hedley Atkins (1938) in his review of 
breast disease, recognized endocrine, neuralgic and psychological components of the 
problem of breast pain(12). He undertook a trial of oestrin in these patients but failed to 
demonstrate a beneficial effect. There are, of course, examples of patients with 
psychosomatic problems referred to the breast clinic but the work of Preece et al (1978) 
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has firmly established the organic nature of most episodes of breast pain. Preece et al 
(1978) compared patients with breast pain with a group of women (referred for 
consideration of a surgical procedure) with varicose veins. The psychological 
assessment was performed using the well validated Middlesex Hospital questionnaire 
(Crown et al, 1970) and showed that there was no increased psychological morbidity in 
the group of women complaining of painful breasts (12). 
 
The development of severe pain and nodularity which may last for the most part 
of the menstrual cycle is considered as abnormal and may interfer significantly with the 
patient's everyday activities. In most cases, aberrant physiological or pathological 
processes underlie the symptom rather than neuroticism. Premenstrual breast pain is 
normal, but 10-15% of patients referred to breast clinics required treatment. 
 
Recently, mastalgia has been classified into three distinct clinical syndromes (1)   
(Preece et al 1976, Bishop & Blarney 1979, Maddox et al 1989). Cyclical mastalgia 
accounts for two-thirds of cases. Cyclical pain, which is usually bilateral (some times it 
may be unilateral), varies during the menstrual cycle and is typically worse in the luteal 
phase and relieved by the onset of the menopause. Non-cyclical pain accounts for the 
remaining one-third, being further divided into true non-cyclical pain and chest wall pain 
which is either felt along the costo-chondral junction (Tietze's syndrome) or the lateral 
chest wall. This classification will identify those patients likely to respond to hormonal 
treatment (cyclical and true non-cyclical) and those who will not (chest wall pain). 
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MASTALGIA   
  Cyclical (Two thirds of Patients) 
  Non Cyclical (One third of patients)   
True 
Chest wall pain 
 Mammography is often utilized and is of potential value to rule out carcinoma 
and show signs of benign breast disease. 
 
FIBROCYSTIC DISEASE 
 There is a miscellany of morphological alterations in the female breast are often 
grouped under the term fibrocystic changes. Fibrocystic changes represent the single 
most common disorder of the breast commonly presenting between 20 and 40 years of 
age with peak incidence just before menopause. One in every fourteen women develop 
palpable cyst. There are three principle patterns of morphological change 1) Cyst 
formation, often with apocrine metaplasia 2) Fibrosis 3) Adenosis. Cysts of the breast 
are usually round and well delimited. Often referred as blue dome cysts (Haagensen’s 
diseases of the breast) (9).  
   
 Cysts develop when the lumina of the ducts and acini become dilated and lined 
by atrophic epithelium. Micro cysts are < 3mm in diameter and gross cysts are > 3mm 
in diameter. Gross cysts originate from blunt ducts and micro cysts.  
 
Mammographically, they are indistinguishable from non calcified solid masses. 
Shape is variable according to the amount of fluid present within it and the amount of 
compression applied. Calcification occurs mostly in cysts that are greater than 10mm in 
diameter. It is present as a peripheral rim. Micro cysts may contain granules of calcified 
debris (milk of calcium).  Ultrasonographically simple cysts are anechoic with posterior 
enhancement. Hemorrhage and infection may cause internal echoes or debris to be 
present. They are only partially mobile as they are attached to the glandular tissue. 
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FIBROADENOMA 
Fibroadenoma (adenofibroma (9)) is a benign tumour composed of stromal and 
epithelial elements. It is the most common tumour of the breast in women younger than 
30 years of age.  They are firm, solitary tumours, and well encapsulated with smooth 
borders which may be lobulated. 
 
Fibroadenomas appear mammographically as well circumscribed round or oval 
masses frequently, with gentle lobulations and rarely exceeding 3cm in size. Myxoid 
degeneration results in coarse nodular calcification. On ultrasound, they appear 
homogeneous and hypoechoic with posterior enhancement and edge shadowing. 
There is no reaction in the surrounding tissue and it is mobile. They may show posterior 
shadowing if calcification or hyaline degeneration is present. They are only slightly 
compressible and have their long axis parallel to the skin as they accommodate 
themselves to the local anatomy defined by beast nodules and cooper’s ligaments with 
blood vessels passing around them. 
 
GIANT FIBROADENOMA 
Giant fibroadenoma is a descriptive term that applies to a fibroadenoma that 
attains an unusually large size, typically greater than 5 cm. Haagensen (9) calls these 
lesions massive adenofibromas in youth to denote their common occurrence in 
adolescent women. 
 
PHYLLODES TUMOR 
Phylloids tumours arise from intra lobular stroma. They can occur at any age 
mostly in the sixth decade. They constitute 1% of all primary tumours of the breast (10).  
A group of circumscribed biphasic tumours, basically analogous to fibroadenomas, 
characterized by a double layered epithelial component arranged in cleft surrounded by 
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an over growing hyper cellular mesenchymal component typically organized in leaf - 
like structures. 
 
Mammographically, it resembles a large lobulated fibroadenoma with high soft 
tissue density. Some margins may be irregular suggesting local invasion. They may 
develop plaque like calcification. Ultrasonographically they are similar to fibroadenomas 
with well defined margins and posterior enhancement. The otherwise uniform echoes 
are usually broken up by fluid spaces. They are very vascular on color Doppler. 
 
PAPILLOMA 
 Overall less than 10% of benign breast neoplasms correspond to papllomas, 
presenting mainly during 4th and 5th decade (10). A proliferation of epithelial and 
myoepithelial cells overlaying fibrovascular stalks creating an arborescent structure 
within the lumen of a duct. Intra ductal papilloma of the breast is divided into central 
(large duct) papilloma located in the sub areolar region and peripheral papilloma arising 
in the Terminal Duct Lobular Unit (TDLU). They are normally solitary and central and 
produce  a serous or bloody discharge . Peripheral papillomas may occur in contiguous 
branches of the ductal system.  
 
Mammographically, a lobulated fairly well circumscribed mass usually in the 
subareolar region is seen. Calcification may be punctate or similar to fibroadenoma. 
Ultrasound will show a solid mass within a dilated duct or cyst. Multiple papillomas tend 
to occur in younger women of less than 30 yrs and appear like fibroadenomas both 
clinically and on imaging. 
 
FIBROMATOSIS (DESMOID TUMOUR) 
 Fibromatosis accounts for less than 0.2% of all breast lesions, more common in 
child bearing age(10). This is a locally aggressive lesion without metastatic potential 
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originates from fibroblasts and myofibroblasts within the breast parenchyma, excluding 
mammary involvement by extension of a fibromatosis arising from the pectoral fascia. 
 
          These have the same characteristics of abdominal desmoid tumors and also 
appear as round or oval circumscribed benign appearing masses. Rarely it may appear 
as a spiculate mass on mammography. Ultrasound may reveal a solid mass 
indistinguishable from a fibroadenoma. 
 
SCLEROSING ADENOSIS 
 Sclerosing adenosis is characterized by a compact proliferation of acini with 
preservation of the luminal epithelial and the peripheral myoepithelial cell layers along 
with a surrounding basement membrane. Micro calcifications are common within the 
glands. 
 
RADIAL SCARS 
A benign lesion on imaging resembles invasive carcinoma. Grossly and at low 
power microscopy it resembles invasive carcinoma because the lobular architecture is 
distorted by the sclerosing process (11). The term radial scar has been applied to small 
lesions and complex sclerosing lesions to large ones that contain a variety of ductal 
epithelial hyperplasia along with sclerosis. They are often multiple and bilateral. 
 
Radial scars are common in post Mastectomy and after large excision biopsies. 
Most are microscopic but some form larger (greater than 1 cm) palpable masses. They 
are benign lesions of unknown etiology that mimic malignancy on imaging. 
Mammogram shows spicules originating from a central nidus. But unlike Carcinoma, it 
does not have a central mass but only a central area of architectural distortion. 
Sonogram shows a hypo echoic mass with dense posterior acoustic shadowing. 
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GALACTOCELE 
 These are cysts containing inspissated milk, occurring in lactating women and in 
late pregnancy. Usual site is the central breast. On mammogram, they may have a 
mottled appearance with fat-fluid level on erect lateral view. On sonogram they appear 
solid sometimes. 
 
LYMPH NODES 
 Axillary lymph nodes are oval masses with a fatty hilum and are usually less 
than 2 cms in size. Intra mammary lymph nodes are seen in the upper outer quadrant, 
posteriorly, as well circumscribed lobulated nodules of less than 1cm in size with a hilar 
notch and lucent center if fatty replacement has occurred. They may not be seen on 
ultrasound. They are seen in diseases like rheumatoid arthritis, sarcoidosis and 
infections like tuberculosis and other bacterial infections. Fine punctate calcifications 
maybe seen in sarcoidosis and are mimicked in patients with rheumatoid arthritis on 
gold therapy. 
 
HEMATOMA 
 Trauma to the breast may result in hematoma formation which may present 
clinically and mammographically as an ill-defined mass mimicking a carcinoma. 
Occasionally, the late sequelae of a hematoma may resemble a carcinoma with micro 
calcification and architectural distortion. Ultrasound shows it to be hypo or hyper echoic 
depending on the duration. Shaggy walled cavities with echogenic debris and fluid that 
move with posture may be seen. 
 
GRANULAR CELL (MYOBLASTOMA) TUMOR 
  This is an extremely rare benign lesion probably of Schwann cell origin with a 
6 % rate of occurrence in the breast and most frequently seen in the 3rd to 5th 
decade(10). The tumor has a fibrous stroma with infiltrative margin mimicking a 
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scirrhous carcinoma clinically and mammographically. Sonographically, a hypo echoic 
mass with post acoustic shadowing and echogenic interface anterior to the hypo echoic 
lesion will be seen. 
 
INFECTIONS: 
ABSCESS: 
 Breast abscess is mostly encountered during lactation or in non-lactating 
women in relation to duct ectasia. Usually occurs in a central or subareolar location 
producing an irregular density with associated trabecular, skin or nipple distortion. 
Ultrasound shows a cyst with internal echoes, shaggy walls, intracavitary ehogenic gas 
bubbles and intense color signals at the hyperemic periphery. 
 
TUBERCULOSIS: 
           Tuberculosis of the breast was first described by Cooper in 1829 as the 
‘scrofulous swelling of the bosom'. Only a few clinical reports have been reported from 
the Indian subcontinent in spite of the high prevalence of other forms of tuberculosis in 
this region. The disease has been reported in the 20-50 years age group. Breast 
tuberculosis may be primary where the breast lesion is the only manifestation of the 
disease or it may be secondary in which a focus of tuberculosis has already been 
diagnosed elsewhere in the body and the disease appears in the breast at a later 
stage. The method of spread to the breast is by the hematogenous or lymphatic routes, 
or by direct extension from adjacent tissues.  
The disease presents in three forms: nodular, diffuse and sclerosing. The 
nodular form is characterized by a slow growing caseating lesion and 
mammographically presents as a dense round area with indistinct margins. The diffuse 
form consists of multiple, intercommunicating foci of tuberculosis within the breast, 
which may caseate leading to ulceration and numerous discharging sinuses. The skin 
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may be thickened, with a tense and tender breast. In addition to the breast lesion, the 
axillary lymph nodes are frequently affected.  
Radiographs show a dense breast and thickened skin. In the sclerosing form, 
excessive fibrosis rather than caseation is the dominating feature. Progress is slow and 
suppuration is rarely seen. The entire breast becomes hard because of the dense 
fibrous tissue and the nipple gets retracted. Increased density of the gland is seen on 
mammography. All the three forms of the disease are indistinguishable from breast 
cancer clinically as well as on mammography. The nodular form of the disease is more 
common and the lesions are hypo echoic sonographically with ill defined margins or 
complex cystic masses may be seen. In cases of diffuse tuberculosis ill-defined 
hypoechoic masses are seen. In patients with sclerosing tuberculosis, increased 
echogenicity of the breast parenchyma is seen with no definite mass.  
FILARIASIS: 
As with tuberculosis, a solitary inflammatory mass surrounding the filarial worms 
may mimic a carcinoma radiologically. 
 
LIPOMA 
          This is a fatty tumor which on mammography appears as a lucent or less radio 
dense lesion with a well defined capsule and smooth rounded margin. Sonographically, 
it has the same echogenicity as surrounding fat. 
 
FAT NECROSIS / OIL CYST 
These are single or multiple, 2-3 cms in diameter and result from trauma which 
is usually surgical. They maybe asymptomatic or may present as a palpable mass. 
Mammogaphically, an irregular spiculated mass with or without calcifications or oil cyst 
or only calcifications may be seen. They may have curvilinear calcifications. 
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Sonographically, hypoechoic mass with posterior acoustic shadowing may be seen. 
Complex mass with mixed echotexture intra cystic soft tissue mass may also be a 
feature. An oil cyst shows echogenic oil floating over watery component. 
 
ADENOLIPOMA / HAMARTOMA 
          These are often large when diagnosed, measuring greater than 6 cm, and are 
soft on clinical examination. Mammographic appearance depends on the fat and 
glandular tissue content. Thin soft tissue density capsule is usually present. 
 
SKIN LESIONS 
Sebaceous Cysts, warts, neurofibromas, keloid scars can be seen in the region 
of the skin. Mammographic opacity is usually very well defined because it is outlined by 
air.  
 
STUDIES RELATED TO BENIGN BREAST DISEASES 
Several studies have been conducted to evaluate the role of combined 
sonomammographic imaging in patients with palpable abnormalities of the breast. 
 
In the ACR BI-RADS (14&15) a mass is defined as a space occupying lesion 
seen in at least 2 projections. If seen in only one projection then it is called as a density. 
  
Lawrence W Basset (15) has described that when the margins of a lesion are 
not uniform throughout, then, the descriptor indicating the portion of greatest concern 
should be used. 
 Stavros et al (16) has reported that a mass to be characterized as benign on 
ultrasound should have 3 or less gentle lobulations. 
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 Color Doppler is an adjunct to ultrasound in the differential diagnosis of benign 
tumors. Malignant tumors are characterized by more than 1 vascular pole (17,18).  
 
 Wendie A Berg et al (19) have studied cystic lesions of the breast with 
sonographic and pathological correlation  and concluded that all clustered  microcysts 
are benign but cysts with thick walls or septations (>=0.5mm), intracystic masses, or 
predominantly solid masses with eccentric cystic foci should be examined at biopsy as 
23% of them had proved to be malignant. Also they have stated that size concordance, 
mammographic, sonographic, pathologic concordances are critical with papillary 
lesions as 2 of 12 lesions excised were malignant. 
  
Ultrasound with high frequency transducer is essential for accurate non invasive 
diagnosis of breast cysts and has showed promise in the differentiation of benign from 
malignant solid masses (20).  However it requires state of the art equipment with 
appropriate technical settings to create an optimal image (21). 
 
 As reported by Manju Bala Popli (22) tuberculosis of the breast occurs in the 
upper outer quadrant of the breast and can appear nodular or diffuse with 
intercommunicating foci and discharging sinuses or sclerosed with increased density of 
the gland on mammography. Multiple chronic discharging sinuses suggest 
Tuberculosis. 
 
 The measured sonographic size of a mass may differ slightly from the 
mammographic size but significant differences cannot be reconciled readily by a 
change in imaging modalities. This principle is important because the majority of breast 
cysts are not visible on mammography (23). Lesions in the axillary region may also be 
more difficult to detect because of the overlying pectoralis muscle causing decreased 
contrast in this region (23). 
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 Breast carcinoma is diagnosed in only 4 % of patients with breast symptoms 
indicating that appropriate management of breast physical findings is important for the 
primary physician (24). 
 
 There is considerable documentation that mammography is less useful in 
younger women due to greater likelihood of dense breast tissue composition (15, 25). 
 
In women younger than 40 years, the normal glandular nodularity may be 
mistaken for dominant masses (27). Women with negative mammograms and 
ultrasound scans are at low risk for cancer but should be followed up at short term 
intervals with clinical examination and imaging if biopsy is not elected by their surgeon / 
clinician (24). Breast thickening is a particularly vague descriptor of a physical finding at 
clinical breast examination that encompasses a wide range of descriptions including 
breast nodularity; diffuse cystic change fibrocystic change and breast fullness (24). In 
this study 78% of the cases with breast thickening were normal when breast ultrasound 
was normal. 
  
One of the various factors leading to false negative findings on mammography 
is the effect of breast density. In the study conducted by Pavel Crystal et al (28) out of 7 
sonographically detected cancers 2 were in patients with BI-RADS category 4 and 5 
were in patients with BIRADS category 3 parenchymal density. No carcinomas were 
detected with BIRADS category 2 density. No statistical difference was found in the 
number of cancers among a range of breast densities. Dense glandular tissue has a 
hyperechoic appearance on sonography, so hypoechoic cancers are easily detected. 
  
According to Stephen H Taplin et al (29) BIRADS assessments and 
management recommendations are consistent for negative and benign assessments 
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and there is evidence of how well terminology consistent with BI-RADS was 
implemented in practice by 1997. 
  
Ultrasound is not only helpful in the depiction of lymph nodes but also 
involvement of skin and pectoral muscle. In posterior lesions, especially those close to 
the chest wall musculature accurate measurement of the size and extension may not 
be possible with mammography prior to surgery (30). 
 
 In the study done by Mahesh K Shetty et al (13), palpable abnormality has a 
variety of descriptors – lump, thickening, knot and cord. In 2002 Mahesh K Shetty et al 
(13) have showed the value of combined sonomammographic assessment in patients 
with palpable breast abnormalities and have reported a sensitivity and negative 
predictive value of 100% each with a specificity of 80%. 40% of the lesions were 
categorized as benign after a combined evaluation showing the value of imaging in 
helping avoid unnecessary biopsies. 
 
 False negative rates of 0-2.6% have been reported in multiple studies for 
combined sonomammographic evaluation in patients with palpable abnormalities of the 
breast (15, 31, 32). 
 
 Moss et al (33) reported a sensitivity of 94.2% and specificity of 67.9% in 368 
patients in who combined sonomammographic evaluation had been performed for 
palpable breast abnormalities and who underwent surgical biopsy. 
 
 Rotten D et al have studied the usefulness of 3D ultrasound in breast 
diseases (34,35). Benign tumors are surrounded by a continuous hyperechogenic rim, 
i.e. the rim is present irrespective of the section plane orientation. In case of 
  35
fibroadenomas, complete wall continuity of the mass was readily apparent. The 
hyperechoic bands of fibrous tissue peripheral to the masses appeared either as 
distinct from the central image (compressive pattern). Three-dimensional ultrasound 
mammography had higher specificity, but lower sensitivity, than two-dimensional 
ultrasound mammography. 
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MATERIALS AND METHODS 
 
Female patients in the pre, peri and post menopausal age groups with benign 
breast disorders who underwent breast ultrasound and mammography from September 
2003 were included in this study. Patients with features of malignancy were excluded 
from the study. Standard nomenclature for characterization of the lesions on 
mammography and ultrasound were used. Subsequently all the patients underwent   
histopathological examinations of lesions in the form of excision biopsy or true cut 
biopsy. 
Patients in whom histopathology could not be done due to practical reasons 
Fine Needle Aspiration Cytology was done. In correlation with the clinical diagnosis and 
FNAC final diagnosis was arrived and patients were treated accordingly. 
 
Methods: 
Cranio-caudal and Medio-Lateral Oblique views of mammographs of both 
breasts were taken –24-30 KV; 100mAs. Ultrasound examination was done with high 
frequency linear transducer of both breasts. 
 
3D volume probe was used to acquire coronal plane which was simply used to 
classify the margins of the lesion into three types of patterns- Retraction, Compression 
and Indeterminate. 
 
 We have compared the sensitivity USG with the mammography using Z test. P 
value less than 0.05 was considered as statistically significant. HPE was considered as 
gold standard. Where HPE is not done due to practical reasons, Fine Needle Aspiration 
Cytology was considered as gold standard. Statistically analysis were done using 
SPSS 11.5 version. (Statistical Package for Social Sciences) 
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COIMBATORE MEDICAL COLLEGE HOSPITAL,  
COIMBATORE 
 
A STUDY OF DIAGNOSTIC ACCURACY IN BENIGN 
BREAST DISEASE WITH SPECIAL REFERENCE TO 
RECENT DIAGNOSTIC TOOLS 
 
Patient Name:      Age:  Sex: 
Serial No.      OP/IP No. : 
Ward / Unit :  
Complaints & History : 
1. History of breast lump-duration and site. 
2. H/o pain and whether related to menstrual cycle 
3. H/o nipple discharge-serous or serosanguinous 
4. H/o fever  
5. H/o intake of oral contraceptive pills or surgeries for the breast 
6. Menstrual history 
7. Marital history 
8. Obstetric history-last child birth and breast feeding 
9. Family h/o of breast diseases 
 
CLINICAL FINDINGS : 
• Palpable lump, thickening, knot, cord 
• Location, size and number 
• Margins, consistency and mobility 
• Associated findings: skin changes, nipple retraction, axillary lymph 
nodes. 
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CLINICAL DIAGNOSIS : 
FINE NEEDLE ASPIRATION CYTOLOGY :  No.    
Date done:       Reported on:   
FINDINGS : 
 
 
 
 
 
 
 
 
 
 
 
BIOPSY  :        No.    
Date done:       Reported on:   
FINDINGS : 
 
  39
MAMMOGRAPHIC FINDINGS: 
• Number, location and density of the lesion(s) 
• Margins- well-defined, ill-defined, spiculated,  obscured 
• Shape - round, oval, irregular  
• Architectural distortion and tenting 
• Calcification  
• Halo sign. 
• Skin thickening  
• Nipple retraction 
• Axillary lymph nodes with benign or malignant features 
 
Impression 
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  SONOGRAPHY: 
 Shape, size, number and location of the lesion(s) 
 Orientation of the lesion (depth: width ratio) 
 Margins    
• distinct/ indistinct 
• thin / thick/ mixed 
• smooth and regular/ irregular, spiculated, 
microcalcifications 
 Echogenicity /echotexture 
• Homogeneous, anechoic/ hypoechoic/ hyperechoic 
• Heterogeneous, mixed echogenicity/ no cystic component 
• Complex predominantly solid 
• Complex predominantly cystic 
 Posterior shadowing/enhancement/combined 
 Effect on surrounding structures-architectural distortion, coopers 
ligament, distortion, edema 
 Associated findings-dilated duct, skin thickening –focal/diffuse, 
skin retraction, calcification, pectoralis muscle invasion, lymph 
nodes 
 Abnormal vascularity 
 3d features: 
Retraction pattern 
Compression pattern 
Indeterminate 
 
Impression 
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OBSERVATION AND RESULTS 
 
Sixty nine patients were included in this study. All patients underwent ultrasound 
of the breast and mammography. All the 69 patients underwent FNAC. 
Histopathological examinations were done for 49 patients.   
 
In Our study out of 69 patients histopathological confirmation was possible in 49 
patients. Of the remaining patients, 10 patients were not willing for surgery because of 
the small size of the lesions and for cosmetic objections and another 10 patients did not 
require biopsy and were conservatively treated. Out of the 49 patients in whom 
histopathological confirmation and FNAC were done, result of the FNAC did not 
correlate with the HPE in 5 patients. Because of difficulty in finding out location of the 
lesion in 3 patients FNAC was negative. In 2 cases of phylloids tumour FNAC was 
unable to diagnose correctly. All other cases FNAC was consistent with 
histopathological examination. 
 
Out of the 49 patients Ultrasound showed positive diagnosis for 46 patients with 
a sensitivity of 93.9%. Whereas mammography was positive was only in 33 patients 
with a sensitivity of 67.3%. Statistical test of proportion showed that Z value is 3.3 with 
the corresponding p value less than 0.001. Hence it is concluded that ultrasound 
produces statistically significant higher sensitivity compared to mammography.  We 
compared sensitivity of ultrasound and mammography keeping gold standard as 
histopathological examination. It is found that ultrasound in general shows the 
sensitivity of 92.8% (positive results for 64 patients out of 69 examined), whereas 
mammography showed the sensitivity of 66.7% (Positive results for 46 out of 69 
patients examined). This difference is statistically significant because the z value is 3.8. 
Hence the corresponding p value is less than 0.001. 
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TABLE 1 
AGE GROUP WISE DISTRIBUTION OF BENIGN BREAST DISEASES 
 
AGE GROUP         
(YRS) 
NO. OF 
PATIENTS 
% 
< 20 15 21.74 
21- 30 26 37.68 
31- 40 21 30.43 
> 41 7 10.14 
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TABLE 2 
ULTRASOUND AND MAMMOGRAPHIC COMPARISION 
 
Mammography Ultrasound 
46 64 
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TABLE 3 
3D SONOGRAPHIC FEATURES OF BENIGN LESIONS 
 
CORONAL PLANE NO. OF LESIONS (N=64) % OF LESIONS 
RETRACTION 1 1.56 
COMPRESSION 58 90.63 
INDETERMINATE 5 7.81 
 
3D SONOGRAPHIC FEATURES OF BENIGN 
LESIONS
RETRACTION COMPRESSION INDETERMINATE
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TABLE 4 
 BENIGN BREAST DISEASE PATTERN 
 
Name of the Disease No. of Patients 
(n=69) 
% 
Fibroadenoma  50 72.46 
Fibrocystic Disease 10 14.49 
Breast Abscess 5 7.25 
Fibroadenosis 2 2.90 
Phylloides tumour 2 2.90 
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TABLE 5 
MAMMOGRAPHICALLY DENSE BREAST  
AGE WISE DISTRIBUTION 
 
AGE GROUP Dense Breast 
< 20 7 
21- 30 7 
31- 40 3 
> 41 1 
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AGE WISE DISTRIBUTION OF 
DENSE BREAST IN MAMMOGRAM
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ILLUSTRATIVE EXAMPLES 
 
 
 
 
 
 
 
 
 
CASE 1 - FIBROCYSTIC DISEASE  
CASE 2 - FIBROCYSTIC DISEASE 
CASE 3 - BREAST ABSCESS 
CASE 4 - TUBERCULAR BREAST ABSCESS 
CASE 5 - FIBROADENOMA   
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CASE 1 - FIBROCYSTIC DISEASE 
 
 
39 year old patient came with H/O left breast lumps. Mammogram showed Category IV 
BI-RADS parenchymal density with obscuration of lesions, not able to comment on 
nature of lesion on the mammography. U/S screening showed dilated ducts with 
multiple cysts suggestive of BI-RADS Grade II lesions – FIBROCYSTIC DISEASE. 
 
 
Cranio-caudal and Medio-lateral oblique view Mammograms of the left breast 
 
 
 
Ultrasound of the left breast showing cysts and dilated ducts 
 
Contd.. 
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3D Ultrasound coronal Image 
 
 
 
 
 
CASE 2 – FIBROCYSTIC DISEASE 
 
 
40 year old patient came with H/O lumps in the left breast for 2 months duration. 
Mammogram showed multiple radiodense lesions in the left breast in all quadrants 
which on Ultrasound screening showed to be multiple cysts with compressive pattern 
on 3D coronal image. Findings were thus suggestive of fibrocystic disease BI-RADS 
Grade II which was proved by Histopathological correlation of the breast tissue  - 
FIBROCYSTIC DISEASE. 
 
 
 
Contd… 
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Cranio-caudal and Medio-lateral oblique view Mammograms of the left breast showing 
multiple radiodense lesions (arrows) 
 
 
 
 
 
Ultrasound screening of left breast with 3D coronal reconstruction showed the cyst 
having well defined margins in the coronal planes with no irregularity of surrounding 
suggestive of compressive pattern. 
Contd.. 
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Histopathology of Left Breast tissue 
 
 
CASE 3 – PYOGENIC BREAST ABSCESS 
 
 
50 year old patient came with H/O lump in the right breast and H/O I&D done for a lump 
in the left axilla. Mammogram shows a radiodense lesion in the supero lateral quadrant 
of Right breast and irregular lesion in the left axilla suggestive a scar. Ultrasound 
showed a complex cystic lesion in the right breast and an irregular skin lesion in the left 
axilla with multiple  hypoechoic lymph nodes. 3D coronal imaging of the lesion in the 
right breast revealed an indeterminate pattern. Findings were suggestive of a breast 
abscess with lymph nodal involvement – BI-RADS Grade II lesion. Histopathology 
proved the lesion in the right breast to be a pyogenic breast abscess 
 
 
 
Cranio-caudal and Medio-lateral oblique view Mammograms of both breasts with 
radiodense lesions in the right superior quadrant and in the left axilla (seen only in the 
MLO views). CC view did not show the lesions because of their depth and lateral 
location. 
Contd… 
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Ultrasound screening of left axilla showing Lymphnodes. The linear hypoechoic lesion 
in the left picture corresponds to the presence of a surgical scar. 
 
 
   
 
3D coronal image of Right Breast lesion 
 
 
 
Histopathology of Right Breast Lesion 
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CASE 4 – TUBERCULOUS BREAST ABSCESS 
 
 
28 year old patient came with H/O discharge from wound in the right breast. 
Mammogram showed bilateral dense breasts with skin discontinuity in the inferior 
aspect. Ultrasound 2D and 3D reconstruction showed an irregular cystic lesion with 
internal echoes  and areas of calcification that was extending from the skin towards the 
deeper planes and into the pleural cavity. Findings were suggestive of Tuberculous 
Breast abscess – BI-RADS Grade II Lesion 
 
 
 
Cranio-caudal and Medio-lateral oblique view Mammograms of the right breast showing 
BI-RADS Category IV parenchymal density and an area of skin discontinuity at the 
inferior aspect (arrow) 
 
  
 
contd.. 
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2D Ultrasound and 3D Reconstruction of right breast lesion 
 
 
CASE 5 – FIBRO ADENOMA 
 
24 year old patient came with complaints of palpable mass in the right breast. 
Mammogram shows a well defined radiodense lesion in the Right supero lateral 
quadrant with specks of calcification. Ultrasound screening showed a well defined 
hypoechoic lesion which showed a compressive pattern on 3D reconstruction and no 
abnormal vascularity on Doppler study. Findings were suggestive of a fibroadenoma – 
BI-RDAS Grade III lesion. Histopathology of the lesion showed it to be a 
Fibroadenoma. 
 
 
Mammogram of the right breast showing well defined radiodense lesion with specks of 
calcification and halo sign in the supero lateral quadrant 
Contd.. 
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2D ultrasound screening and Doppler study of the right breast lesion. 
 
  
 
             3D coronal reconstruction     Histopathology of the right breast lesion. 
            of right breast lesion 
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DISCUSSION 
 
The role of mammography in patients with benign breast diseases is to 
delineate the lesion with its shape and location. Mammography is also helpful to rule 
out malignant features in the involved breast and also to screen the opposite breast. 
 
In our study of 69 patients mammography was useful in detecting 46 of the 
lesions with the sensitivity of 66.7%. 18 patients had mammographically dense breast  
hence lesions could not be made out. In another 5 patients mammography was unable 
to give the features of specific diagnosis. 
 
Linda Moy et al (32), in their study of 829 patients, have concluded that 
mammography failed to detect lesions in patients with dense breasts. In our series of 
69 patients mammography failed to detect lesions in 23 patients as 18 out of these 23 
patients had mammographically dense breast. 
 
Bennet C et al (25) and Lawrence W Bassett (15) have documented the 
decreased sensitivity of mammography in dense breast mostly in young women. In our 
study of 69 patients 18 patients had mammographically dense breast, of whom 14 were 
less than 30 years of age. 
 
According to Thomas M Kolb et al (26) who have studied 11130 women, have 
documented that sensitivity of mammography to detect lesions was 77.6%.  
Mammographic sensitivity for breast lesions declines significantly with increasing breast 
density. Addition of screening US significantly increases detection of small lesions and 
depicts significantly more lesions and at smaller size and lower stage than does 
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physical examination. In their study sensitivity of mammography was 78%. Addition of 
screening US to screening mammography increased the sensitivity to 97%. 
 
In our study, ultrasound of breast was done in all the 69 patients, ultrasound 
breast was able to pickup the diagnosis correctly in 64 patients with the sensitivity of 
92.8% USG breast was particularly more useful in women with dense breast where 
mammography had limited sensitivity. USG was also helpful in the characterization of 
the lesions and was helpful in differentiation of cystic from solid masses. Of the 5 
patients whom USG breast failed to characterize the specific lesions, 3 had fibrocystic 
disease and two had fibroadenosis. Ultrasound has limited sensitivity in small lesions of 
less than 1 cm which may be the cause for its inability to detect small lesions in these 
patients. 
 
Additional imaging with sonography is appropriate in most instances except in 
lesions that are mammographically benign. Sonography may obviate the need for 
intervention by showing benign causes for palpable abnormalities such as cysts. 
 
 In their study of 103 patients Jacqueline S Kaiser et al (24) have found that 
sensivity of mammography was 60% and sensivity of ultrasound was 100% in detecting 
the lesion showing superiority of ultrasound over mammography. In our series of 69 
patients sensitivity of ultrasound (92.8%) was superior to mammography (66.7%). 
 
          Logan Young et al have stated in their study (20) that ultrasound with high 
frequency transducer is essential for accurate non invasive diagnosis of breast cysts 
and has showed promise in the differentiation of benign from malignant solid masses.  
 
             Mahesh K Shetty et al (13) in their study of 398 patients have also stated that 
Sonography is complementary to mammography in patients with palpable 
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abnormalities, its superiority over mammography is in being able to show lesions 
obscured by dense breast tissue and in characterizing palpable lesions that are 
mamographically visible or occult. Mammography is complementary to sonography 
because of its ability to screen the remainder of the ipsilateral and contralateral breast 
for clinically occult lesions. It has been reported that the accuracy of sonography is 
comparable with that of mammography as a screening modality for breast lesion. 
 
In their study of 1517 women Pavel Crystal et al(28) have found that breast 
screening with sonography in the population of women with dense breast tissue is 
useful in detecting lesions not seen in mammography. 
  
 Isabelle le conte et al,(37) in their study of 4236 ptients, have found that 
sonograpy is an useful adjunct after mammography for the detection of lesions 
particularly in the dense breast. In their study sensitivity of ultrasound was 88% and 
that of mammography was 56%.  
 
            In one of our patients, extension of the cystic lesion into the pleural cavity was 
detected only on ultrasound and helped us to come to a diagnosis of tuberculous 
abscess.  
  
Current surgical therapy by John. L.Cameron says that Addition of screening 
sonography to screening mammography could increase by 42% the number of 
nonpalpable lesions diagnosed. The benefits were greatest in women with dense 
breasts, as mammograms have the lowest sensitivity in this population (39).  
 
            3D ultrasound was helpful in additionally characterizing most of the lesions. 
Compressive pattern was seen in 3D ultrasound almost all benign lesions (58 out of 64 
benign lesions) and in one patient retraction pattern was seen and further investigation 
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delineated atypical cells suspicious for malignancy. Five Patients showed indeterminate 
pattern on 3D ultrasound with subsequent diagnosis of breast abscess in 4 patients and 
in one patient with a benign lesion, which on further investigation delineated fibrocystic 
disease. In these 5 patients 3D ultrasound did not provide any better information than 
was available with 2D ultrasound. Hence 3D ultrasound was not helpful in lesions 
causing lesser degrees of architectural distortions. (Lesions which had irregular or 
lobulated margins on 2D ultrasound could not be grouped into either of these patterns 
where therefore indeterminate for benign or malignant lesions on 3D ultrasound). 
  
Rotten D et al (34, 35) also found in their study of the usefulness of 3D 
ultrasound in breast diseases and these 2 patterns of compression & retraction were 
preferentially associated with benign and malignant lesions respectively. Three 
dimensional ultrasound mammography had a higher specificity but lower sensitivity 
than two dimensional mammography in their study. 
 
In Our study, out of 69 patients histopathological confirmation was possible in 
49 patients. Of the remaining patients, 10 patients were not willing for surgery because 
of the small size of the lesions and for cosmetic objections and another 10 patients did 
not require biopsy and were conservatively treated. Out of the 49 patients in whom 
histopathological confirmation and FNAC were done, result of the FNAC did not 
correlate with the HPE in 5 patients because of difficulty in finding out location of the 
lesion in 3 patients and in 2 cases phylloids tumour FNAC was unable to diagnose. All 
other cases FNAC was consistent with histopathological examination. 
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CONCLUSION 
             
MAMMOGRAPHY IS SUPERIOR TO ULTRASOUND IN THE DETECTION OF 
MICROCALCIFICATION. 
 
            SONOGRAPHY IS COMPLEMENTARY TO MAMMOGRAPHY IN PATIENTS 
WITH PALPABLE ABNORMALITIES OF THE BREAST. 
 
           SONOGRAPHY’S SUPERIORITY OVER MAMMOGRAPHY IS IN IT’S ABILITY 
TO SHOW THE PRESENCE AND EXTENT OF LESIONS THAT ARE OBSCURED BY 
DENSE BREAST TISSUE AND IN CHARACTERISING PALPABLE LESIONS THAT 
ARE MAMMOGRAPHICALLY NOT VISIBLE OR OCCULT. 
 
           ULTRASONOGRAM IS MOST HELPFUL IN CHARACTERISING CYSTIC 
LESIONS AND STUDYING THE INTERNAL COMPONENT OF THESE LESIONS. 
 
           THREE DIMENSIONAL ULTRASOUND IS HELPFUL IN ADDITIONALLY 
CHARACTERISING MOST OF THE LESIONS THAT CAUSE GREATER DEGREES 
OF ARCHITECTURAL DISTORTION.  
 
COMPRESSION PATTERN PROVES TO BE MORE SPECIFIC FOR BENIGN 
LESIONS.  
 
THREE DIMENSIONAL ULTRASOUND IS NOT VERY SPECIFIC FOR 
LESIONS CAUSING LESSER DEGREES OF ARCHITECTURAL DISTORTION. 
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S.No. Name Age
IP. 
/OP.No.
Clinical 
Diagnosis FNAC Mammography Ultrasound 3D USG
BIRADS 
Probable 
Diagnosis HPE Follow-up
1 Parvathy 45 OP 8140
Lt. Fibro 
Adenoma
Fibrocystic 
Disease Dense Breast
Round Shape, Well defined B/L 
Fibrocystic disease, 
Fibroadenoma Lt. Comp II
Fibrocystic 
Disease
Conservative 
treatment
2 Natchammal 37 IP 17348
Lt. Fibro 
cystic 
disease
Fibrocystic 
Disease
Dense Breast Fibroadenoma 
Lt. Brem RD Round Shape, Well Defined Comp II
Fibroscystic 
Disease
Conservative 
treatment
3 Rajalakshmi 19 IP18068
Rt. 
Fibroaden
oma
Fibroadeno
ma Dense Breast
Fibroadenoma Rt. Breast 
Round Shape, Well Defined Comp III
Excision 
Fibroadeno
ma Rt. Excision done
4 Krishnaveni 3 OP9954
Lt. Fibro 
Adenoma
Fibroadeno
ma Fibroadenoma CT Multiple fibroadenoma Lt. Rt. Comp II
Excision 
Fibroadeno
ma Rt. Excision Done
5 Karuppathal 27 IP32368
Rt. 
Fibroaden
oma
Fibroadeno
ma Dense Breast Rt. Fibroadenoma Comp III
Fibroadeno
ma Rt. Excision Done
6 Thilagamani 28 OP36416
Lt. Fibro 
Adenoma
Fibroadeno
ma Lt. Round Fibro adenoma
Lt. Fibroadenoma Rt. Small 
lesions Comp IV
Fibroadeno
ma Lt. Excision Done
7 Janaki 35 OP 6883
Lump Rt. 
Breast
Fibrocystic 
Disease
Benign Lesion Lt. Side 
Fibrocystic Disease B/L Multiple Fibroadenoma Comp III
Floride 
Adenosis Excision Done
8 Saroja 39 IP36916
Lump Rt. 
Breast
Fibrocystic 
Disease
Multiple Benign Lesion 
fibrocystic disease Giant Fibroadenoma Rt. Comp IV
Fibrocystic 
Disease
Incision biopsy 
conservative 
management
9 Soujath 17 IP 51391
Fibroaden
oma
Fibroadeno
ma Dense Breast Lt. Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
10 Kalyani 31 IP17347
Lt. 
Fibroaden
oma
Lt.Fibro 
adenoma Fibroadenoma Lt Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
11 Revathi 24 OP 6992
Lump Rt. 
Breast
Breast 
Abcess Lt. Radio Dense Lesion Lt. Breast Abscess
indetermi
nate II
Breast 
Abcess Drained
12 Indira 34 IP 32247
Lt. 
Fibroaden
oma
Fibroadeno
ma Lt. Fibro adenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
13 Kaliyammal 55 IP 66568
Lump Rt. 
Breast Abscess Rt. Radio Dense lesion Rt. Abscess
indetermi
nate II
Breast 
Abcess Drained
14 Shanthi 34 IP 65174
Lt. 
Fibroaden
oma
Fibroadeno
ma Lt. Fibro adenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
15 Prabhavathy 29 IP 52969
Lt. 
Fibroaden
oma
Lt.Fibro 
adenoma Lt. Fibro adenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
16 Musthirabanu 14 OP 4450
Lt. 
Fibroaden
oma
Lt.Fibro 
adenoma Dense Breast Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
17 Nagamani 20 OP 8631
Lump Lt. 
Breast
Fibroadeno
ma Lt. Fibro adenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
18 Vijaya 37 OP 4217
Fibroaden
oma Lt. 
Breast
Fibroadeno
ma Lt. Fibro adenoma Fibroadadenoma Lt. Comp III
Fibroadeno
ma Excision biopsy
19 Sundarammal 27 IP 49437
Lump Lt. 
Breast
Breast 
Abcess
Radiodense Lesion with ill 
defined margins Breast abscess
Intermedi
ate III
Breast 
Abcess Drained
20 Kamalam 23 OP 553
Fibroaden
oma Rt.
Fibroadeno
ma Dense Breast Fibroadenoma Rt. Breast R WD Comp III
Fibroadeno
ma Excision done
21 Angathal 55 IP 13888
Lump Rt. 
Breast
Fibro cystic 
disease
Rt. Giant Fibroadenoma and 
phyllaids tumour Phylloids tumour Rt Comp III
Phylloides 
Tumour Excision biopsy
22 Preethamary 23
OP 
20347
Lt. Fibro 
Adenoma
Fibroadeno
ma Lt. Fibro adenoma Lt. Fibroadenoma Comp IV
Fibroadeno
ma Excision done
23 Rajeswari 18
OP 
48157
Lt. Fibro 
Adenoma
Fibroadeno
ma Lt. Fibro adenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
24 Shakila 27 IP 40141
Lt. Fibro 
Adenoma
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision 
25 Sumithra 21 IP 1889
Rt. 
Fibroaden
oma
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
26 Kamala 20
OP 
12087
Lump Rt. 
Breast
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
27 Amaravathy 24 IP 65758
Rt. 
Fibroaden
oma
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
28 Naseera 19 OP 2716
Rt. 
Fibroaden
oma
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision done
29 Remja 32 OP 9194
Lt. 
Fibroaden
oma
Fibroadeno
ma Lt. Fibroadenoma Fibrocystic Disease Lt. Comp II
Fibrocystic 
disease Excision done
30 Dhanalakshmi 37 IP 5525
Lt. 
Fibroaden
oma
Fibroadeno
ma matoid 
hyperplasia Lt. Fibroadenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision 
31 Amsabegam 22 OP7567
Rt. 
Fibroaden
oma
Fibroadeno
ma matoid 
hyperplasia Dense Breast
Rt. Fibroadenoma with 
fibrocystic changes Comp III
Fibroadeno
ma Excision 
32 Lakshmi 39 IP5608
Lump Rt. 
Breast
Fibrocystic 
Diseases
Dense Breast BD, Rt 
Fibroadenoma
Fibrocystic Diseasese Rt. 
Fibroadenoma
indetermi
nate III
Fibroadeno
ma Excision 
33 Kavitha 27 IP 35387 Lumpt Lt
Fibroadeno
ma Dense Breast Fibroadenoma Comp III
Fibroadeno
ma Excision 
34 Kaliammal 47 IP 55337
Fibroaden
oma Lt. 
Fibrocystic 
Diseases Giant Fibroadenoma Phylloids tumour Benign Comp III
Phylloides 
Tumour Excision 
35 Kamarinisha 21 OP1475
Lt. 
Abscess
Breast 
Abcess
B/L Dense Breasts, Dense 
lesion Lt. Breast abscess Lt
Intermedi
ate II
Tuberculou
s breast 
abcess Drained
36 Thulasimani 45 OP4334
Lt. 
Abscess
Breast 
Abcess Bilateral Dense Breast Breast Abcess
Intermedi
ate II
Breast 
Abscess Aspirated
37 Fathima 19 IP43375
Fibroaden
oma Rt.
Fibroadeno
ma Dense Breast Fibroadenoma Rt. Comp III
Fibroadeno
ma Excision
38 Suganthi 35 IP40960
Lump Lt. 
Breast
Fibrocystic 
Disease Dense Breast B/L Fibrocystic Diseases - II
Fibrocystic 
Disease
lt. Excision of 
Lump
39 Maheswari 19 IP55952 FAD Rt
Fibroadeno
ma Fibroadenoma Fibroadenoma Rt. Comp III
Fibroadeno
ma Excision
40 Prabha 25 IP56625 Rt FAD
Fibroadeno
ma Dense Breast Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision
41 Kalaimagal 32 IP 54167 Lt FAD
Fibroadeno
ma Lt. Fibroadenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision
42 Vijayalakshmi 43 IP 37970
Lt. 
Fibroaden
oma
Fibroadeno
ma Lt. Fibroadenoma Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision
43 Parvathy 50 IP 36743 Rt. FAAD
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision Done
44 Radha 23 IP 62651 Rt. FAD
Fibroadeno
ma Dense Breast Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision Rt.
45 Muthulakshmi 16 IP 62719 Rt. FAD
Fibroadeno
ma Dense Breast Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision
46 Selvi 19 IP 51048
Fibroaden
oma Lt.
Fibroadeno
ma Dense Breasts Lt. Fibroadenoma Comp III
Fibroadeno
ma Excision
47 Sabeena 19 IP11763 Lt. FAD
Fibroadeno
ma Dense Breasts Lt. Fibroadenoma Comp II
Fibroadeno
ma Excision
48 Leena 23 IP27809 Rt. FAD
Fibroadeno
ma
Dense Breasts & Benign 
Lesion Rt. Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision
49 Parvathy 32 IP52861 FAD Rt.
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Fibroadeno
ma Excision
50 Krishnaveni 20 OP2917
Lt. 
Fibroaden
oma
Fibrosystic 
disease Lt. Benign lesions
Rt. Fibroadenoma Lt. 
Fibroadenoma Comp III
Conservative 
treatment
51 Kalyani 31
OP 
12347
lt. Breast 
Multiple 
Fibroaden
oma
Fibroadeno
ma Fibroadenoma Lt. Fibroadenoma Lt. Comp III
Conservative 
treatment
52 Vidhya 35 OP 8451
Lt. 
Fibroaden
oma
Lt. 
Fibroadeno
ma Lt. Fibroadenoma Lt. Fibroadenoma Comp III
Conservative 
Management
53 Rathinam 23 OP6827
Rt. 
Fibroaden
oma
Fibroadeno
ma Fibroadenoma Rt. Rt. Fibroadenoma Comp III
Conservative 
treatment
54 Omana 28 OP3011
Lt. 
Fibroaden
oma
Fibro 
adenoma Lt. Fibroadenoma Lt. Fibroadenoma Comp III
Conservative 
Management
55 Jagadeswari 19 OP4603
Rt. 
Fibroaden
oma
Fibro 
adenoma Rt. Fibroadenoma Rt. Fibroadenoma Comp III
Conservative 
Management
56 Kavitha 20 OP17153
Lt. 
Fibroaden
oma
Fibro 
adenoma Lt. Fibroadenoma Lt. Fibroadenoma Comp III
Conservative 
Management
57 Vijayalakshmi 22 OP484
Lt. 
Fibroaden
oma
Fibro 
adenoma Lt. Fibroadenoma Lt. Fibroadenoma Comp III Conservative
58 Valliyammal 21 OP3902
Rt. 
Fibroaden
oma
Fibro 
adenoma Rt. Fibroadenoma Lt. Fibroadenoma BRITOS III Comp III Conservative
59 Easwari 25 OP1240
Lump Rt. 
Breast
Fibro 
adenoma Lt. Fibroadenoma Lt. Fibroadenoma Comp III Conservative
60 Valarmathi 30 OP5806
Fibrocystic 
Disease
Fibrocystic 
Disease Dense Breast Fibrocystic Disease Comp III Conservative
61 Parvathy 35 OP7891
Lump Lt. 
Breast
Fibro 
adenoma Lt. Fibroadenoma Lt. Fibroadenoma Comp III Conservative
62 Ranjitha 26 OP232 Lt. Lump
Fibro 
adenoma Lt. Fibroadenoma Lt. Fibroadenoma Comp III Conservative
63 Valli 37 OP636 Lt. Lump
Fibrocystic 
Disease Dense Breast Lt. Fibroadenoma Comp II Conservative
64 Renganayaki 21 OP2343
Rt. 
Fibroaden
oma
Fibro 
adenoma Rt. Fibroadenoma Rt. Fibrocystic Disease Comp II Conservative
65 Vasuki 30 OP9568 Lump Rt.
Fibro 
adenosis Rt. Benign Lesion Rt. Fibrocystic Disease Comp II Conservative
66 Jayamani 37 OP39774 Lump Rt.
Fibrocystic 
diseases Rt. Benign Lesion Rt. Fibrocystic Disease Comp II Conservative
67 Chellammal 35 OP3684
Rt. 
Fibroaden
oma
Fibroadeno
ma Rt. Fibroadenoma Rt. Fibroadenoma Comp III Conservative
68 Roja 35 OP2748
Rt. 
Fibroaden
oma
Rt.Atypical 
cells Multiple Benign Masses
Rt. 12B B IV Fibroadenoma, 
Fibroadenosis, Smart Cyst Lt. RE IV, III
Conservative 
Treatment
69 Geetha 24 IP25822
Lt. 
Fibroaden
oma
Fibrocystic 
Disease Normal Focal Fibrocystic Champs Comp II Conservative
